Press release
Corporate Press
August 21, 2013

Evonik opens analytical center for animal feed in Singapore

  • Analytical center dedicated to support animal feed industry in Asia Pacific
  • Center to provide amino acid analysis of feed and feed ingredients
  • Reinforcement of Evonik’s commitment to contribute to healthier and more sustainable nutrition

Hanau/Singapore. Evonik Industries opens its first analytical center for animal feed in South Asia. Located in Singapore, this multi-million US dollar investment will complement the specialty chemicals company network of analytical centers for feed amino acids in Hanau (Germany) and Beijing (China).

The analytical center will provide the full range of powerful amino acid analytical services to regional and global feed manufacturers thus maximizing the nutritional value of their feed. In depth analysis of amino acid concentration in feed ingredients benchmarked against the requirements of different animals allows feed manufacturer to select the best suitable ingredients, to provide more consistent quality in feed, and to increase the efficiency of their production.

"Asia is the fastest growing animal and feed production region of the world, and we felt it was essential to position this lab in Singapore in order to better support our customers in this important region," explained Dr Alfred Petri, Senior Vice President Sales & Marketing in the Health & Nutrition Business Unit of Evonik, during today’s opening ceremony. "This investment drives our commitment of being a strategic partner to our customers." With this analytical center, Evonik has increased its technical presence in the region to a total of 20 nutritionists, chemists, and engineers, all dedicated to providing value-added technical services to the animal feed industry.

The range of services provided by this new analytical center include wet chemistry analysis of amino acid content in raw materials, compound feed, premixes and physiological samples (AMINOLab®), wet chemistry analysis of supplemented amino acids (AMINOBatch®), and near infrared reflectance spectroscopy analytical services for prediction of amino acid content in raw materials (AMINONIR®).

In addition to providing nutrient analysis of feed and feed ingredients, this analytical center will also offer feed manufacturers the opportunity to be trained in amino acid analytics and to learn how to best apply this knowledge into this production for more consistent, high-quality feed leading to improved animal production, better sustainability, and increased profitability.

"The analytical center will allow us to provide our customers with the most up-to-date training on analytical methods as well as the most accurate analytical information available about the nutrient quality of their feeds and feed ingredients," stated Dr Rob Payne, Director of Nutrition and Technical Sales for Asia South.

Evonik is the only company in the world to manufacture and sell all four essential amino acids for modern animal feed: MetAMINO® (DL-methionine), ThreAMINO® (L-threonine) and TrypAMINO® (L-tryptophan)and Biolys® (L-lysine source). Combined with more than 50 years of experience in amino acid analysis and nutrition, Evonik is the amino acid expert providing valuable and innovative solutions for its customers, which allow them to produce feed and animals effectively and efficiently in a sustainable manner.

About Evonik

Evonik, the creative industrial group from Germany, is one of the world leaders
in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms.

Evonik is active in over 100 countries around the world. In fiscal 2012 more than 33,000 employees generated sales of around €13.6 billion and an operating profit (adjusted EBITDA) of about €2.6 billion.


In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.